Carbiotix launches second generation diagnostic platform

Press releases   •   Feb 11, 2020 09:00 CET

Carbiotix (publ) ("Carbiotix") announces today that the company has launched its second generation diagnostic platform for gut health based on Next Generation Sequencing (NGS). The company will now offer a NGS test with three samples as a standard and at a cost that is 1/3 the cost of the nearest competitor on the market per sample.

About Carbiotix AB

Gut health solutions to meet your wellness goals

Carbiotix is an award-winning biotechnology company focused on simple, affordable and effective gut health solutions and their impact on the microbiome.


  • Carbiotix AB
  • Scheelevägen 22
  • 22363 Lund
  • Sweden

Subscribe via RSS